On the one hand, cell therapy led to a significantly higher percentage of CD11b+ myeloid cells (Figure 11A) in the remote area (49.28 ± 3.92 vs. 31.17 ± 2.72; p = 0.01) of MIC hearts as compared with MI hearts. Here, ITGAM is linked to myocardial infarction.